Saharsh Rao Davuluri

Saharsh Rao Davuluri

Active Director Whole-Time Director DIN 02753145
DIN 02753145 First appointment Oct 1999 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Past companies 4 historical roles
Total affiliations 5 Since Oct 1999
Shareholding value •••• Premium profile

About Saharsh Rao Davuluri

Data last updated:

Saharsh Rao Davuluri is a Whole-Time Director at Neuland Laboratories Ltd (since 2009). The companies operate in Pharma. Neuland Laboratories Ltd reported revenue of ₹1,497 Cr (FY 2025). Earlier, Saharsh Rao Davuluri was a Director at Asvi Therapeutics Private Limited (from 2020) and Director at Neuland Health Sciences Private Limited (from 1999) and 2 more.

DIN 02753145
Primary Designation Whole-Time Director
Industry Pharma
First Appointment 14 Oct 1999
Oldest Company Age 42 yrs
Largest company Neuland Laboratories Ltd · ₹1,497 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Neuland Laboratories Ltd L85195TG1984PLC004393
Whole-Time Director01 Jun 20091984₹1,497 Cr (FY 2025)Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Asvi Therapeutics Private Limited U24230TG2020PTC146436
Director01 Dec 20202020Strike Off
Director14 Oct 19991993₹580 Cr (FY 2017)Amalgamated
Director01 Oct 20102008Strike Off
Director23 Apr 20122012₹61.52 Cr (FY 2017)Amalgamated

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Saharsh Rao Davuluri

NameDINCompanyDesignation
Abhijit Ajay MajumdarNeuland Laboratories LtdCfo
Homi Rustam Khusrokhan00005085Neuland Laboratories LtdDirector
Mauricio Futran11699767Neuland Laboratories LtdAdditional Director
Pallavi Joshi Bakhru01526618Neuland Laboratories LtdDirector
Prasad Raghava Menon00005078Neuland Laboratories LtdDirector
Ramamohan Rao Davuluri00107737Neuland Laboratories LtdWhole-Time Director
Ravi Shankar Gopinath00803847Neuland Laboratories LtdDirector
Sarada BhamidipatiNeuland Laboratories LtdCompany Secretary
Sucheth Rao Davuluri00108880Neuland Laboratories LtdWhole-Time Director
Sugata Sircar01119161Neuland Laboratories LtdDirector

Directorship timeline

Open interactive timeline →
Asvi Therapeutics Private Limited
Neuland Health Sciences Private Limited
Cato Research Neuland India Private Limited
Neuland Pharma Research Private Limited
Premium access

Shareholding and investment profile for Saharsh Rao Davuluri

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Saharsh Rao Davuluri

Saharsh Rao Davuluri currently holds 1 directorship: Neuland Laboratories Ltd (Whole-Time Director, since 01 Jun 2009, revenue ₹1,497 Cr (FY 2025)).

Saharsh Rao Davuluri was first appointed on 14 Oct 1999 as Director at Neuland Health Sciences Private Limited. The most recent appointment on record is 01 Dec 2020 at Asvi Therapeutics Private Limited.

Saharsh Rao Davuluri held 4 earlier board appointments: Asvi Therapeutics Private Limited (Director, from 01 Dec 2020); Neuland Health Sciences Private Limited (Director, from 14 Oct 1999); Cato Research Neuland India Private Limited (Director, from 01 Oct 2010); Neuland Pharma Research Private Limited (Director, from 23 Apr 2012).

The current boards of Saharsh Rao Davuluri's companies include Abhijit Ajay Majumdar (Neuland Laboratories Ltd), Homi Rustam Khusrokhan (Neuland Laboratories Ltd), Mauricio Futran (Neuland Laboratories Ltd), Pallavi Joshi Bakhru (Neuland Laboratories Ltd), Prasad Raghava Menon (Neuland Laboratories Ltd), Ramamohan Rao Davuluri (Neuland Laboratories Ltd), among others.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available